Inspire Medical Systems (INSP) closed at $55.10 on November 20, 2026, down 2.1% from the previous close, on volume of 519,293 shares (30-day average 690,082).
Data as of November 20, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 2, 2026 | Call Spread | 20-Nov-2670 : 80 C | 304 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 19, 2026. See the largest for 5, 30, 60 and 90 days
MedTech poised to outperform in 2027, Leerink says as Abbott upgraded
Seeking Alpha News (Thu, 19-Nov 10:49 AM ET)
Nyxoah obtains default judgment in patent infringement case against Inspire Medical Systems
Seeking Alpha News (Wed, 18-Nov 2:30 AM ET)
Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference
Globe Newswire (Tue, 17-Nov 4:05 PM ET)
Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
Globe Newswire (Tue, 3-Nov 4:05 PM ET)
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
Globe Newswire (Mon, 2-Nov 4:28 PM ET)
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
Business Wire (Mon, 12-Oct 4:05 PM ET)
Globe Newswire (Fri, 9-Oct 11:55 AM ET)
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
Globe Newswire (Mon, 5-Oct 4:05 PM ET)
Globe Newswire (Thu, 1-Oct 4:03 PM ET)
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Inspire Medical Systems trades on the NYSE stock market under the symbol INSP.
As of November 20, 2026, INSP stock price declined to $55.10 with 519,293 million shares trading.
INSP has a beta of 1.47, meaning it tends to be more sensitive to market movements. INSP has a correlation of 0.06 to the broad based SPY ETF.
INSP has a market cap of $1.59 billion. This is considered a Small Cap stock.
Last quarter Inspire Medical Systems reported $207 million in Revenue and $.14 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.05.
In the last 3 years, INSP traded as high as $257.40 and as low as $38.91.
The top ETF exchange traded funds that INSP belongs to (by Net Assets): IJR, VTI, VB, IWM, VBK.
INSP has underperformed the market in the last year with a price return of -34.0% while the SPY ETF gained +5.2%. INSP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.7% and -17.2%, respectively, while the SPY returned -10.1% and -5.9%, respectively.
INSP support price is $54.80 and resistance is $57.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INSP shares will trade within this expected range on the day.